Can an AI-generated drug slow aging? 6 notes

An AI-generated drug, rentosertib, being developed for idiopathic pulmonary fibrosis was associated with reductions in predicted biological age across six proteomic aging clocks, according to a study published Sept. 7 in Nature Biotechnology. Here are six things to know: The post Can an AI-generated drug slow aging? 6 notes appeared first on Becker's Hospital Review | Healthcare News & Analysis.

Original Source

Read the full article at Beckershospitalreview →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.